A drug recall is the removal or correction of a marketed medical product that is defective or potentially harmful. Recalls are a core mechanism of post-marketing safety: they let problems discovered after approval be addressed quickly. This article explains how recalls are classified and managed from a standards and process perspective; it is not clinical or regulatory advice.
Who initiates a recall
Most recalls in the United States are voluntary, carried out by the manufacturer either on its own initiative or at the FDA’s request. The FDA also has authority to require recalls of certain products. Either way, the agency oversees the process, classifies the recall by risk, and monitors that it is carried out effectively.
The three recall classes
| Class | Level of hazard |
|---|---|
| Class I | A reasonable probability that use will cause serious harm or death. |
| Class II | Use may cause temporary or medically reversible harm, or the probability of serious harm is remote. |
| Class III | Use is unlikely to cause harm but the product violates regulations (for example, a labelling or quality defect). |
A related action, market withdrawal, addresses a minor issue not subject to legal action, while a medical device safety alert warns of a risk from a device.
What triggers a recall
Recalls can be prompted by manufacturing defects discovered through quality control, contamination, incorrect labelling or dosing information, stability failures, or safety signals detected through pharmacovigilance and adverse-event reporting. The ability to act quickly depends on traceability — the GMP requirement that every batch can be identified and followed through the supply chain.
How recalls are communicated and tracked
The FDA publishes recalls in its Enforcement Report and issues public notices for higher-risk cases. Manufacturers must notify distributors and, where appropriate, the public, and demonstrate that affected product has been retrieved or corrected. The recall is closed only when the agency is satisfied it has been effective.
Why recalls illustrate good record-keeping
A recall is only possible because of disciplined documentation: batch records, distribution data and a quality system that links a defect back to its source. This is the same logic of provenance and traceability that underpins reproducible research and trustworthy metadata. For the manufacturing-quality foundations, see our Good Manufacturing Practice explainer; for the regulator’s wider role, see the FDA and drug approval.
Frequently asked questions
What is a drug recall?
A drug recall is the removal or correction of a marketed medicine that is defective or potentially harmful, used to address safety or quality problems found after a product reaches the market.
What are the FDA recall classes?
Class I covers products that could cause serious harm or death; Class II covers products that may cause temporary or reversible harm; and Class III covers products unlikely to cause harm but that breach regulations.
Are recalls usually ordered by the FDA?
Most recalls are voluntary actions by manufacturers, often at the FDA’s request. The agency oversees, classifies and monitors recalls, and has authority to require them for certain products.
How does traceability make recalls possible?
Good Manufacturing Practice requires that every batch be identifiable and traceable through the supply chain, so a defect can be tracked to its source and affected product retrieved efficiently.